Cardiovascular Digital Solutions Segmentation
Component (Devices, Software)
Devices segment is likely to account for around 58.7% cardiovascular digital solutions market share by 2037, owing to the increasing uptake of wearable technology, remote monitoring technologies, and the need for continuous, real-time health data. Continued advancements in technology and increased health consciousness are contributing to this growth. In August 2024, GE Healthcare announced the CE mark of its Vscan Air SL wireless handheld ultrasound solution for rapid cardiac assessment.
Application (Cardiac monitoring and diagnosis, CVD health informatics, Cardiac rehab programs)
By 2037, cardiac monitoring and diagnosis segment is set to capture over 57.1% cardiovascular digital solutions market share, owing to growing incidence rates of CVDs, increased use of remote patient monitoring, and constant improvements in wearable technology. The growth of this segment is brought about by new developments in wearable devices such as smartwatches and patch monitors, which enable the tracking of heart rates, ECG, and blood pressure. In March 2024, Wellysis partnered with Arthella Solutions to launch innovative remote monitoring services for cardiac health in the U.S.
Our in-depth analysis of the cardiovascular digital solutions market includes the following segments:
|
Component |
|
|
Application |
|
|
Deployment Mode |
|
|
End use |
|
